Table. Proportion of Patients With Subsequent Colonoscopy in the 6 Months Following SBTa.
| Type of insurance | No. (%) | |||
|---|---|---|---|---|
| All | mt-sDNA cohort | FIT cohort | FOBT cohort | |
| Commercial or Medicare insurance | ||||
| Patients with at least 6 mo of CE on or after SBT, No. | 80 951 | 5993 | 50 840 | 24 118 |
| Subsequent colonoscopy within 6 mo after SBT | 12 823 (15.8) | 581 (9.7) | 7753 (15.2) | 4489 (18.6) |
| With polyp removal | 7416 (57.8) | 455 (78.3) | 4433 (57.2) | 2528 (56.3) |
| Without polyp removal | 5608 (43.7) | 145 (25.0) | 3425 (44.2) | 2038 (45.4) |
| Medicare insurance | ||||
| Patients with at least 6 mo of CE on or after SBT, No. | 6716 | 297 | 4207 | 2212 |
| Subsequent colonoscopy within 6 mo after SBT | 788 (11.7) | 36 (12.1) | 509 (12.1) | 243 (11.0) |
| With polyp removal | 544 (69.0) | 23 (63.9) | 340 (66.8) | 181 (74.5) |
| Without polyp removal | 267 (33.9) | 15 (41.7) | 181 (35.6) | 71 (29.2) |
| Commercial insurance | ||||
| Patients with at least 6 mo of CE on or after SBT, No. | 74 235 | 5696 | 46 633 | 21 906 |
| Subsequent colonoscopy within 6 mo after SBT | 12 035 (16.2) | 545 (9.6) | 7244 (15.5) | 4246 (19.4) |
| With polyp removal | 6872 (57.1) | 432 (79.3) | 4093 (56.5) | 2347 (55.3) |
| Without polyp removal | 5341 (44.4) | 130 (23.9) | 3244 (44.8) | 1967 (46.3) |
Abbreviations: CE, continuous enrollment; FIT, fecal immunochemical test; FOBT, fecal occult blood test; mt-sDNA, multitarget stool DNA; SBT, stool-based tests.
a
Colonoscopy after an SBT does not indicate a positive SBT result, as screening test results are not available in claims data.